Topiramate in the prevention of migraine: a review of its efficacy, tolerability, and acceptability

References

• BigalMERapoportAMLiptonRB2003Assessment of migraine disability using the Migraine Disability Assessment (MIDAS) Questionnaire: a comparison of chronic migraine with episodic migraineHeadache433364212656704
   PubMed Web of Science ®Google Scholar
• BrandesJL2002Global trends in migraine care: results from the MAZE surveyCNS Drugs16Suppl 113812196035
   PubMed Web of Science ®Google Scholar
• BrandesJLSaperJRDiamondM2004Topiramate for migraine prevention: a randomized controlled trialJAMA2919657314982912
   PubMed Web of Science ®Google Scholar
• BrandesJL2005Practical use of topiramate for migraine preventionHeadache45Suppl 1S667315833092
   PubMed Web of Science ®Google Scholar
• BussoneGDienerHCPfeilJ2005Topiramate 100mg/day in migraine prevention: a pooled analysis of double-blind randomised controlled trialsInt J Clin Pract59961816033621
   PubMed Web of Science ®Google Scholar
• DahlöfCHGDimenäisE1995Migraine patients experience: poor subjective well-being/quality of life even between attacksCephalalgia153167758095
   PubMed Web of Science ®Google Scholar
• D’AmicoDGencoSPeriniF2004Workplace disability in migraine: an Italian experienceNeurol Sci25Suppl 3S251215549550
   PubMed Web of Science ®Google Scholar
• D’AmicoDUsaiSGrazziL2004The impact of primary headaches on patients’ lives: Italian experience with the MIDAS and the SF-36 questionnairesHeadache Care11238
   Google Scholar
• DiamondMDahlofCPapadopoulosG2005Topiramate improves health-related quality of life when used to prevent migraineHeadache4510233016109116
   PubMed Web of Science ®Google Scholar
• DienerHCTfelt-HansenPDahlofC2004Topiramate in migraine prophylaxis. Results from a placebo-controlled trial with propranolol as an active controlJ Neurol2519435015316798
   PubMed Web of Science ®Google Scholar
• DowsonAJLipscombeSSenderJ2002Migraine in primary care advisors. New guidelines for the management of migraine in primary careCurr Med Res Opin184143912487508
   PubMed Web of Science ®Google Scholar
• DuelandANLeiraRBurkeTA2004The impact of migraine on work, family, and leisure among young women – a multinational studyCurr Med Res Opin20159560415462692
   PubMed Web of Science ®Google Scholar
• DuelandANLeiraRCabelliST2005The impact of migraine on psychological well-being of young women and their communication with physicians about migraine: a multinational studyCurr Med Res Opin21129730516083540
   PubMed Web of Science ®Google Scholar
• EdmeadsJFindlayHTugwellP1993Impact of migraine and tension-type headache on life-style, consulting behaviour, and medication use: a Canadian population surveyCan J Neurol Sci2013178334575
   PubMed Web of Science ®Google Scholar
• FraunfelderFWFraunfelderFTKeatesEU2004Topiramate-associated acute, bilateral, secondary angle-closure glaucomaOphthalmology1111091114711721
   PubMed Web of Science ®Google Scholar
• GoadsbyPJ2005Migraine pathophysiologyHeadache45Suppl 1S142415833086
   PubMed Web of Science ®Google Scholar
• GrayRNGoslinREMcCroryDC1999Evidence Report: Drug Treatments for the Prevention of Migraine Technical Review 23, February (Prepared for the Agency for Health Care Policy and Research under Contract No. 290-94-2025 Available from the National Technical Information Service; NTIS Accession No. 127953)
   Google Scholar
• Headache Classification Subcommittee of the International Headache Society2004The International Classification of Headache Disorders, 2nd edCephalalgia24S1816015595989
   PubMed Web of Science ®Google Scholar
• HenryPAurayJPGaudinAF2002Prevalence and clinical characteristics of migraine in FranceNeurology59232712136063
   PubMed Web of Science ®Google Scholar
• International Headache Society Clinical Trials Subcommittee2000Guidelines for controlled trials of drugs in migraine: second editionCephalalgia207658611167908
   PubMed Web of Science ®Google Scholar
• JhingranPDavisSMLaVangeLM1998MSQ: Migraine-Specific Quality-of-Life Questionnaire. Further investigation of the factor structurePharmacoeconomics137071710179706
   PubMed Web of Science ®Google Scholar
• JohnsonBAAit-DaoudNBowdenCL2003Oral topiramate for treatment of alcohol dependence: a randomised controlled trialLancet36116778512767733
   PubMed Web of Science ®Google Scholar
• LaunerLJTerwindtGMFerrariMD1999The prevalence and characteristics of migraine in a population-based cohort: the GEM studyNeurology535374210449117
   PubMed Web of Science ®Google Scholar
• LiptonRBGoadsbyPJSawyerJPC2000Migraine: diagnosis and assessment of disabilityRev Contemp Pharmacother116373
   Web of Science ®Google Scholar
• LiptonRBHamelskySWStewartWFSilbersteinSDLiptonRBDalessioDJ2001Epidemiology and impact of migraineWolff’s headache and other head painNew YorkOxford University Press85107
   Google Scholar
• LiptonRBStewartWFDiamondS2001Prevalence and burden of migraine in the United States: data from the American Migraine Study IIHeadache416465711554952
   PubMed Web of Science ®Google Scholar
• LiptonRBLibermanJNKolodnerKB2003Migraine headache disability and health-related quality-of-life: a population-based case-control study from EnglandCephalalgia234415012807523
   PubMed Web of Science ®Google Scholar
• McElroySLArnoldLMShapiraNA2003Topiramate in the treatment of binge eating disorder associated with obesity: a randomized, placebo-controlled trialAm J Psychiatry1602556112562571
   PubMed Web of Science ®Google Scholar
• MacGregorEABrandesJEikermannA2004Impact of migraine on patients and their families: the Migraine And Zolmitriptan Evaluation (MAZE) survey – Phase IIICurr Med Res Opin2011435015265259
   PubMed Web of Science ®Google Scholar
• OsterhausJTGuttermanDLPlachetkaJR1992Healthcare resource and labor costs of migraine in the USPharmacoeconomics2677610146980
   PubMedGoogle Scholar
• RoncolatoMFabbriLRecchiaG2000An epidemiological study to assess migraine prevalence in a sample of Italian population presenting to their GPsEur Neurol43102610686468
   PubMed Web of Science ®Google Scholar
• ShankRPGardockiJFStreeterAJ2000An overview of the preclinical aspects of TPM: pharmacology, pharmacokinetics, and mechanism of actionEpilepsia41S3910768292
   PubMed Web of Science ®Google Scholar
• SilbersteinSD2000Practice parameter: evidence-based guidelines for migraine headache (an evidence-based review): report of the Quality Standards Subcommittee of the American Academy of NeurologyNeurology557546210993991
   PubMed Web of Science ®Google Scholar
• SilbersteinSDSaperJRFreitagFGSilbersteinSDLiptonRBDalessioDJ2001Migraine: diagnosis and treatmentWolff’s headache and other head painNew YorkOxford University Press121237
   Google Scholar
• SilbersteinSDNetoWSchmittJ2004Topiramate in migraine prevention: results of a large controlled trialArch Neurol61490515096395
   PubMed Web of Science ®Google Scholar
• SilbersteinSDBen-MenachemEShankRP2005Topiramate monotherapy in epilepsy and migraine preventionClin Ther271546515811478
   PubMed Web of Science ®Google Scholar
• SolomonGDSantanelloN2000Impact of migraine and migraine therapy on productivity and quality of lifeNeurology55Suppl 2S293611089517
   PubMed Web of Science ®Google Scholar
• SteinerTJScherAIStewartWF2003The prevalence and disability burden of adult migraine in England and their relationships to age, gender and ethnicityCephalalgia25192712950377
   PubMed Web of Science ®Google Scholar
• StewartWFShechterALiptonRB1994Migraine heterogeneity. Disability, pain intensity, and attack frequency and durationNeurology44Suppl 42439
   Google Scholar
• TepperSJD’AmicoDBaosV2004Guidelines for prescribing prophylactic medications for migraine: a survey among headache specialist physicians in different countriesHeadache Care126772
   Google Scholar
• TerwindtGMFerrariMDTijhuisM2000The impact of migraine on quality of life in the general population: the GEM studyNeurology556242910980723
   PubMed Web of Science ®Google Scholar
• Von KorffMRStewartWFSimonDJ1998Migraine and reduced work performance. A population-based diary studyNeurology501741459633720
   PubMed Web of Science ®Google Scholar
• WelchKM2005Brain hyperexcitability: the basis for antiepileptic drugs in migraine preventionHeadache45Suppl 1S253215833087
   PubMed Web of Science ®Google Scholar